SLNO - Soleno Therapeutics CEO sells stock worth ~$3.33M
2023-12-14 14:28:07 ET
More on Soleno Therapeutics
- Soleno Therapeutics: Impressive Data, But Never Forget Amarin
- Soleno draws Buy from Guggenheim on rare disease therapy
- Soleno Therapeutics prices its underwritten public offering at $20 per share
- Seeking Alpha’s Quant Rating on Soleno Therapeutics
- Historical earnings data for Soleno Therapeutics
For further details see:
Soleno Therapeutics CEO sells stock worth ~$3.33M